• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON CARIBE LTD. BD BACTEC¿ LYTIC/10 ANAEROBIC/F CULTURE VIALS (PLASTIC); SYSTEM, BLOOD CULTURING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON CARIBE LTD. BD BACTEC¿ LYTIC/10 ANAEROBIC/F CULTURE VIALS (PLASTIC); SYSTEM, BLOOD CULTURING Back to Search Results
Model Number 442022
Device Problem Contamination (1120)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/04/2022
Event Type  malfunction  
Manufacturer Narrative
Date of event is unknown.The date received by manufacturer has been used for this field.Medical device expiration date: unknown.A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.Device manufacture date: unknown.
 
Event Description
It was reported that bd bactec¿ plus anaerobic/f culture vials (plastic) were contaminated which led to false patient results.Additional blood culture testing was performed, and the results were negative.Three patients were treated with bactrim based on the false results, but there was no report of adverse impact.The following information was provided by the initial reporter: erroneous results and adverse effect: were erroneous results and event reported? we are concerned the results were erroneous.How many false positives/negatives did the customer receive? we have 3 patients with same organism (2 in (b)(6), 1 in (b)(6)) what confirmatory testing was performed that determined the results were erroneous? more blood cultures ordered and were negative.Were any erroneous results reported to the doctors? yes- it has not been confirmed the results were erroneous but we are considering all possibilities as this is very unusual.If yes, were any patients treated based on erroneous results? treatment was initiated as patients were critically ill-outside of the one culture of stenotrophomonas if yes, did the erroneous treatment have any adverse impact to the patient(s)? na.Has this organism been reported and any treatment was initiated based on this result? all patients were treated with bactrim and all 3 patient¿s were in the icu-different rooms, no additional cultures growing same.
 
Manufacturer Narrative
The following fields have been corrected: b5: describe event d1: medical device brand name: bd bactec¿ lytic/10 anaerobic/f culture vials (plastic) d2a: common device name: system, blood culturing.D2b: medical device type: mdb.D4: catalog: 442021.Lot # 1314589.Exp date: 31-aug-2022.Udi (b)(4).G5: pma/510(k)# k123903.H.6 investigation summary: upon further evaluation it was noticed that complaint received was from a product already expired.Investigation cannot be conducted to the retention samples since the product is already expired.A complaint history review was conducted and only the current complaint was found relating to the incident lot number and the ¿as reported¿ defect code.The batch history record was not reviewed as the lot is expired, nonetheless batch history records are always reviewed prior to product release.Product insert warnings and precautions sections states that prior to use, each vial should be examined for evidence of contamination such as cloudiness, bulging or depresses septum, or leakage.Vials showing evidence of contamination should not be used.Also prior to use, the user should examine the vial for evidence of damage or deterioration.Vials displaying turbidity, contamination, or discoloration (darkening) should not be used.The specimen must be collected using sterile techniques to reduce the chance of contamination.Do not use culture vials past their expiration date.Complaint is unconfirmed.No corrective actions were required.A cross functional team continually monitors all product complaints for trends and determines if any additional actions are necessary beyond the current investigational process.H3 other text : see h.10.
 
Event Description
It was reported that bd bactec¿ lytic/10 anaerobic/f culture vials (plastic) were contaminated which led to false patient results.Additional blood culture testing was performed, and the results were negative.Three patients were treated with bactrim based on the false results, but there was no report of adverse impact.The following information was provided by the initial reporter: erroneous results and adverse effect: ¿ were erroneous results and event reported? we are concerned the results were erroneous.¿ how many false positives/negatives did the customer receive? we have 3 patients with same organism (2 in may, 1 in july).¿ what confirmatory testing was performed that determined the results were erroneous? more blood cultures ordered and were negative: ¿ were any erroneous results reported to the doctors? yes- it has not been confirmed the results were erroneous but we are considering all possibilities as this is very unusual.¿ if yes, were any patients treated based on erroneous results? treatment was initiated as patients were critically ill-outside of the one culture of stenotrophomonas ¿ if yes, did the erroneous treatment have any adverse impact to the patient(s)? na ¿ has this organism been reported and any treatment was initiated based on this result? all patients were treated with bactrim and all 3 patient¿s were in the icu-different rooms, no additional cultures growing same.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD BACTEC¿ LYTIC/10 ANAEROBIC/F CULTURE VIALS (PLASTIC)
Type of Device
SYSTEM, BLOOD CULTURING
Manufacturer (Section D)
BECTON DICKINSON CARIBE LTD.
vicks drive
lot no. 6
cayey PR
Manufacturer (Section G)
BECTON DICKINSON CARIBE LTD.
vicks drive
lot no. 6
cayey PR
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key15352776
MDR Text Key305687478
Report Number2647876-2022-00190
Device Sequence Number1
Product Code MDB
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K123903
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 11/08/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date08/31/2022
Device Model Number442022
Device Catalogue Number442021
Device Lot Number1314589
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/04/2022
Initial Date FDA Received09/02/2022
Supplement Dates Manufacturer Received12/08/2022
Supplement Dates FDA Received12/21/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/10/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-